Viewing nowMepid Extended-Release Tablet 150 mg (Levamisole)
Rebamipide 150mg
Tablet · Prescription medication
Palmgen Science Co., Ltd.

MFDS item code 202501328 · Approved 2025.05.28 · Insurance code 670105600
Treatment of acute and chronic gastritis exacerbation through improvement of gastric mucosal lesions (erosions, bleeding, etc.)
This medication is used to improve lesions such as erosions, bleeding, redness, and swelling of the gastric mucosa that occur during acute exacerbation of acute and chronic gastritis.
Adults should take 1 tablet twice a day, once in the morning and once in the evening. This medicine should be swallowed whole, and should not be divided or chewed.
This medicine should not be given to patients who have had allergic reactions to its ingredients. While taking this medicine, gastrointestinal disturbances, infections, myalgia, and other adverse reactions may occur, but most are mild symptoms. Serious adverse reactions, such as hypersensitivity reactions like shock or anaphylaxis, leukopenia, thrombocytopenia, and liver dysfunction may occur rarely, so if any unusual symptoms appear, consult a doctor immediately. Pregnant women or those who may become pregnant should only use this medication when the benefits outweigh the risks, and nursing mothers are advised to avoid breastfeeding. The safety in children and adolescents has not been adequately confirmed, so it should be used with caution. Elderly patients may have decreased physiological function, so they should pay particular attention to adverse reactions such as gastrointestinal symptoms. This medicine should be kept out of the reach of children, and transferring it to other containers is not advisable as it can affect quality.
Gastrointestinal disorders (nausea, abdominal distension, upper abdominal pain, constipation, diarrhea, indigestion), infections and parasitic infections (nasopharyngitis, epididymitis, pharyngotonsillitis), musculoskeletal and connective tissue disorders (myalgia, arthralgia), neurological disorders (dizziness, headache), skin and subcutaneous tissue disorders (dry skin, eczema, pruritus), mental disorders (depression, insomnia), respiratory system disorders (cough, oropharyngeal pain), blood system disorders (leukopenia),
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Do not store in overly hot or cold places, and avoid direct sunlight.
White round extended-release tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRebamipide 150mg
Tablet · Prescription medication
Palmgen Science Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Korea Otsuka Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sinphong Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Yuhan Corporation

Rebamipide 100mg
Tablet · Prescription medication
Jongkundang Corporation

Rebamipide 100mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Rebamipide 100mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.